Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
230 hedge funds and large institutions have $1.96B invested in Arena Pharmaceuticals Inc in 2019 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 83 increasing their positions, 58 reducing their positions, and 25 closing their positions.
60% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 25
43% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 58
7% more funds holding
Funds holding: 215 → 230 (+15)
21% less capital invested
Capital invested by funds: $2.47B → $1.96B (-$506M)
28% less call options, than puts
Call options by funds: $12M | Put options by funds: $16.7M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$24.9M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$16.7M |
| 3 |
State Street
Boston,
Massachusetts
|
+$14.8M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$12.5M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
+$12.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$46.5M |
| 2 |
PA
Perceptive Advisors
New York
|
-$24M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.2M |
| 4 |
Primecap Management
Pasadena,
California
|
-$8.95M |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$8.09M |
ARNA Hedge Fund Activity: Q3 2019 in Review
230 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2019, worth a combined $1.96B — down 21% from $2.47B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new ARNA positions and 25 closed out — a net gain of 15 holders — while 83 added to existing stakes and 58 trimmed.
The largest buyer was PFM Health Sciences, adding an estimated $24.9M. The largest seller was Fidelity Investments, cutting an estimated $46.5M.
- 230 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2019, up from 215 in Q2 2019.
- Funds reported $1.96B of Arena Pharmaceuticals Inc stock for Q3 2019, down 21% quarter-over-quarter.
- 40 funds opened new Arena Pharmaceuticals Inc positions in Q3 2019 and 25 closed out, a net change of +15 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q3 2019 was PFM Health Sciences, an estimated $24.9M added.
- The largest Arena Pharmaceuticals Inc seller in Q3 2019 was Fidelity Investments, an estimated $46.5M sold.
Based on aggregated 13F filings for Q3 2019.